This report studies the global market size of Phenylketonuria (PKU) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Phenylketonuria (PKU) in these regions. This research report categorizes the global Phenylketonuria (PKU) market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. Phenylketonuria (PKU) refers to a genetic disorder and the disease is inherited from one?s parents. The patient suffers from a metabolic defect, in which the body stops being able to break down phenylalanine amino acid that is compromised of protein. Phenylalanine starts getting stored in the blood stream and it damages the brain in consequence. PKU is caused due a defect in the gene which helps to produce phenylalanine hydroxylase. Absence of phenylalanine hydroxylase leads to a buildup of phenylalanine in the body. Timely diagnosis and treatment helps in terminating the symptoms of PKU and avoid brain damage. The classification of Phenylketonuria (PKU) includes medications, supplements and others, and the revenue proportion of supplements in 2016 is about 34.48% and the revenue proportion of medications is about 42.47%. Phenylketonuria (PKU) is widely used in household, hospital and other field. The most proportion of Phenylketonuria (PKU) is in household, and the sales proportion in 2016 is about 61.54%. North America is the largest consumption place, with a consumption market share nearly 57.18% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 29.28%. In 2017, the global Phenylketonuria (PKU) market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Phenylketonuria (PKU) market based on company, product type, application and key regions. The various contributors involved in the value chain of Phenylketonuria (PKU) include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Phenylketonuria (PKU) include Biomarin Vitaflo Mead Johnson Nutricia Abbott Prominmetabolics Cambrooke Juvela Firstplay Dietary Market Size Split by Type Medications Supplements Market Size Split by Application Household Hospital Market size split by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Phenylketonuria (PKU) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. To understand the structure of Phenylketonuria (PKU) market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Phenylketonuria (PKU) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Phenylketonuria (PKU) with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Phenylketonuria (PKU) submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Phenylketonuria (PKU) are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Phenylketonuria (PKU) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Phenylketonuria (PKU) Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Phenylketonuria (PKU) Market Size Growth Rate by Type 1.4.2 Medications 1.4.3 Supplements 1.5 Market by Application 1.5.1 Global Phenylketonuria (PKU) Market Size Growth Rate by Ap
